The Utility of Maternal Placental Growth Factor (PlGF) for Prediction of Pre-Eclampsia in Pregnancies Complicated By Sickle Cell Disease
Evangelia Vlachodimitropoulou(Mount Sinai Hospital), Ann Kinga Malinowski(Mount Sinai Hospital), T. Balasubramanian(Garden City University College), Richard Ward(University of Tennessee Health Science Center), J.C.P. Kingdom(Ottawa Hospital), Kevin H.M. Kuo(University Health Network), Nadine Shehata(Mount Sinai Hospital)
Cited by 2
Related Papers
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia
|New England Journal of Medicine|2020|320
Online haemodiafiltration: definition, dose quantification and safety revisited
|Nephrology Dialysis Transplantation|2013|256
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study
|Blood|2018|165
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency
|New England Journal of Medicine|2019|162